Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

346 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Proton beam therapy for children and adolescents and young adults (AYAs): JASTRO and JSPHO Guidelines.
Mizumoto M, Fuji H, Miyachi M, Soejima T, Yamamoto T, Aibe N, Demizu Y, Iwata H, Hashimoto T, Motegi A, Kawamura A, Terashima K, Fukushima T, Nakao T, Takada A, Sumi M, Oshima J, Moriwaki K, Nozaki M, Ishida Y, Kosaka Y, Ae K, Hosono A, Harada H, Ogo E, Akimoto T, Saito T, Fukushima H, Suzuki R, Takahashi M, Matsuo T, Matsumura A, Masaki H, Hosoi H, Shigematsu N, Sakurai H. Mizumoto M, et al. Among authors: terashima k. Cancer Treat Rev. 2021 Jul;98:102209. doi: 10.1016/j.ctrv.2021.102209. Epub 2021 Apr 16. Cancer Treat Rev. 2021. PMID: 33984606 Free article. Review.
Japan society of clinical oncology/Japanese society of medical oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors, cooperated by the Japanese society of pediatric hematology/oncology.
Naito Y, Mishima S, Akagi K, Igarashi A, Ikeda M, Okano S, Kato S, Takano T, Tsuchihara K, Terashima K, Nishihara H, Nishiyama H, Hiyama E, Hirasawa A, Hosoi H, Maeda O, Yatabe Y, Okamoto W, Ono S, Kajiyama H, Nagashima F, Hatanaka Y, Miyachi M, Kodera Y, Yoshino T, Taniguchi H. Naito Y, et al. Among authors: terashima k. Int J Clin Oncol. 2020 Mar;25(3):403-417. doi: 10.1007/s10147-019-01610-y. Epub 2020 Jan 24. Int J Clin Oncol. 2020. PMID: 31974683 Free PMC article.
The Japan Society for Neuro-Oncology guideline on the diagnosis and treatment of central nervous system germ cell tumors.
Nakamura H, Takami H, Yanagisawa T, Kumabe T, Fujimaki T, Arakawa Y, Karasawa K, Terashima K, Yokoo H, Fukuoka K, Sonoda Y, Sakurada K, Mineharu Y, Soejima T, Fujii M, Shinojima N, Hara J, Yamasaki K, Fujimura J, Yamasaki F, Takahashi M, Suzuki T, Sato I, Nishikawa R, Sugiyama K. Nakamura H, et al. Among authors: terashima k. Neuro Oncol. 2022 Apr 1;24(4):503-515. doi: 10.1093/neuonc/noab242. Neuro Oncol. 2022. PMID: 34671804 Free PMC article.
Long-term outcome of centrally located low-grade glioma in children.
Terashima K, Chow K, Jones J, Ahern C, Jo E, Ellezam B, Paulino AC, Okcu MF, Su J, Adesina A, Mahajan A, Dauser R, Whitehead W, Lau C, Chintagumpala M. Terashima K, et al. Cancer. 2013 Jul 15;119(14):2630-8. doi: 10.1002/cncr.28110. Epub 2013 Apr 26. Cancer. 2013. PMID: 23625612 Free article.
Clinical characteristics, treatment, and survival outcome in pediatric patients with atypical teratoid/rhabdoid tumors: a retrospective study by the Japan Children's Cancer Group.
Yamasaki K, Kiyotani C, Terashima K, Watanabe Y, Kanamori M, Koga Y, Hata N, Iwasaki F, Goto H, Koh K, Kurihara J, Tokunaga S, Arakawa Y, Hasegawa D, Kosaka Y, Hara J. Yamasaki K, et al. Among authors: terashima k. J Neurosurg Pediatr. 2019 Nov 15:1-10. doi: 10.3171/2019.9.PEDS19367. Online ahead of print. J Neurosurg Pediatr. 2019. PMID: 31731266
Intensity-modulated radiotherapy (IMRT) in pediatric low-grade glioma.
Paulino AC, Mazloom A, Terashima K, Su J, Adesina AM, Okcu MF, Teh BS, Chintagumpala M. Paulino AC, et al. Among authors: terashima k. Cancer. 2013 Jul 15;119(14):2654-9. doi: 10.1002/cncr.28118. Epub 2013 Apr 30. Cancer. 2013. PMID: 23633429 Free article.
A common deletion at BAK1 reduces enhancer activity and confers risk of intracranial germ cell tumors.
Sonehara K, Kimura Y, Nakano Y, Ozawa T, Takahashi M, Suzuki K, Fujii T, Matsushita Y, Tomiyama A, Kishikawa T, Yamamoto K, Naito T, Suzuki T, Yamaguchi S, Miwa T, Sasaki H, Kitagawa M, Ohe N, Fukai J, Ogiwara H, Kawamura A, Miyawaki S, Matsuda F, Kiyokawa N, Ichimura K, Nishikawa R, Okada Y, Terashima K. Sonehara K, et al. Among authors: terashima k. Nat Commun. 2022 Aug 2;13(1):4478. doi: 10.1038/s41467-022-32005-9. Nat Commun. 2022. PMID: 35918310 Free PMC article.
A prospective study of allogeneic transplantation from unrelated donors for chronic granulomatous disease with target busulfan-based reduced-intensity conditioning.
Osumi T, Tomizawa D, Kawai T, Sako M, Inoue E, Takimoto T, Tamura E, Uchiyama T, Imadome KI, Taniguchi M, Shirai R, Yoshida M, Ando R, Tsumura Y, Fuji H, Matsumoto K, Shioda Y, Kiyotani C, Terashima K, Onodera M, Matsumoto K, Kato M. Osumi T, et al. Among authors: terashima k. Bone Marrow Transplant. 2019 Jan;54(1):168-172. doi: 10.1038/s41409-018-0271-9. Epub 2018 Jun 29. Bone Marrow Transplant. 2019. PMID: 29959437 Clinical Trial. No abstract available.
346 results